يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Bernat Miguel Huguet"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Pellino, Gianluca, Solís-Peña, Alejandro, Kraft, Miquel, Huguet, Bernat Miguel, Espín-Basany, Eloy

    المصدر: Colorectal Disease. 23:2173-2181

  6. 6
  7. 7

    المساهمون: Institut Català de la Salut, [Sampayo-Cordero M, Malfettone A] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. [Miguel-Huguet B] Department of Surgery, Hospital de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain. [Pérez-García JM] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Institute of Breast Cancer, Quiron Group, Barcelona, Spain. [Llombart-Cussac A] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Hospital Arnau de Vilanova, Universidad Católica de Valencia 'San Vicente Mártir', Valencia, Spain. [Cortés J] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Institute of Breast Cancer, Quiron Group, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pérez-López J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    Scientia
    International Journal of Environmental Research and Public Health
    Volume 17
    Issue 18
    International Journal of Environmental Research and Public Health, Vol 17, Iss 6590, p 6590 (2020)

    مصطلحات موضوعية: Pediatrics, Health, Toxicology and Mutagenesis, Mucopolysaccharidosis, lcsh:Medicine, law.invention, 0302 clinical medicine, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedades raras [ENFERMEDADES], Clinical trials, systematic review, Randomized controlled trial, enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::enfermedades genéticas ligadas al cromosoma X::retraso mental ligado al cromosoma X::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::mucopolisacaridosis II [ENFERMEDADES], law, nonrandomized study, Medicine, clinical studies, Mucopolysaccharidosis type II, terapéutica::farmacoterapia::terapia enzimática::tratamiento de sustitución enzimática [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Mucopolysaccharidosis II, 0303 health sciences, mucopolysaccharidosis, Enzyme replacement therapy, Rare diseases, Systematic review, Meta-analysis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Genetic Diseases, X-Linked::Mental Retardation, X-Linked::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Mucopolysaccharidosis II [DISEASES], Assaigs clinics, Malalties congènites, Malalties rares, Goals, enzyme replacement therapy, Cohort study, medicine.medical_specialty, rare disease, Article, 03 medical and health sciences, Rare Diseases, Humans, case report, 030304 developmental biology, business.industry, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases [DISEASES], lcsh:R, Public Health, Environmental and Occupational Health, Enzims - Ús terapèutic, randomized clinical trial, medicine.disease, meta-analysis, business, 030217 neurology & neurosurgery, Therapeutics::Drug Therapy::Enzyme Therapy::Enzyme Replacement Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Assaigs clínics, Rare disease

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10

    المساهمون: [Sampayo-Cordero M, Malfettone A] Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. [Miguel-Huguet B] Colorectal Unit, Department of Surgery, Hospital de Bellvitge, Barcelona, Spain. [Pardo-Mateos A] Albiotech consultores y redacción científica S.L., Madrid, Spain. [Pérez-García J] Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. IOB, Institute of Oncology, QuironSalud Group, Madrid & Barcelona, Spain. [Llombart-Cussac A] Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. FISABIO - Hospital Arnau de Vilanova, Valencia, Spain. [Moltó-Abad M, Pérez López J] Unitat de Malalties Minoritàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: ORPHANET JOURNAL OF RARE DISEASES
    r-FISABIO. Repositorio Institucional de Producción Científica
    instname
    Scientia
    r-FISABIO: Repositorio Institucional de Producción Científica
    Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
    Orphanet Journal of Rare Diseases
    Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-11 (2019)

    مصطلحات موضوعية: 0301 basic medicine, Meta-analysis, Information Science::Communications Media::Publications::Review Literature as Topic::Systematic Reviews as Topic [INFORMATION SCIENCE], Idursulfase, Systematic review, lcsh:Medicine, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Clinical studies, 0302 clinical medicine, Clinical endpoint, Pharmacology (medical), Mucopolysaccharidosis type II, terapéutica::farmacoterapia::terapia enzimática::tratamiento de sustitución enzimática [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Genetics (clinical), Mucopolysaccharidosis II, Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], education.field_of_study, Case reports, General Medicine, Evidence-based medicine, Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Genetic Diseases, X-Linked::Mental Retardation, X-Linked::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Mucopolysaccharidosis II [DISEASES], Enzyme replacement therapy, Malalties rares, medicine.drug, medicine.medical_specialty, Ciencias de la información::medios de comunicación::publicaciones::literatura de revisión como asunto::revisiones sistemáticas como asunto [CIENCIA DE LA INFORMACIÓN], Population, Iduronate Sulfatase, Ressenyes sistemàtiques (Investigació mèdica), enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::trastornos heredodegenerativos del sistema nervioso::retraso mental ligado al cromosoma X::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::mucopolisacaridosis II [ENFERMEDADES], 03 medical and health sciences, Mucopolysaccharidosis type I, Rare Diseases, Internal medicine, medicine, Humans, education, business.industry, Research, lcsh:R, Publication bias, 030104 developmental biology, business, 030217 neurology & neurosurgery, Therapeutics::Drug Therapy::Enzyme Therapy::Enzyme Replacement Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT]

    وصف الملف: application/pdf